{"nct_id":"NCT02699606","title":"A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2016-07-08","start_date_type":"ACTUAL","primary_completion_date":"2021-10-12","primary_completion_date_type":"ACTUAL","completion_date":"2024-03-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}